Epidemiology of Hepatitis C Virus Infection in Australia

Overview

Journal Gastroenterol Jpn

Specialty Gastroenterology

Date 1993 May 1

PMID 7689506

Citations 1

Authors

G C Farrell

M Weltman

J Dingley

R Lin

Affiliations

Soon will be listed here.

Citing Articles

Seroprevalence of hepatitis C virus in rural population of Bangladesh.

Khan M, Mustafa M, Ahmad N, Alam M, Baig R, Chowdhry Z Indian J Gastroenterol. 2010; 29(1):38-9.

PMID: 20373087 DOI: 10.1007/s12664-010-0010-7.

References

Archer G, Buring M, Clark B, Ismay S, Kenrick K, Purusothaman K . Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust. 1992; 157(4):225-7. DOI: 10.5694/j.1326-5377.1992.tb137122.x. View

Kaldor J, Archer G, Buring M, Ismay S, Kenrick K, Lien A . Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust. 1992; 157(4):227-30. DOI: 10.5694/j.1326-5377.1992.tb137123.x. View

Hollinger F, Lin H . Community-acquired hepatitis C virus infection. Gastroenterology. 1992; 102(4 Pt 1):1426-9. DOI: 10.1016/0016-5085(92)90791-v. View

Lin R, Yatuhashi H, Yano M, Farrell G . Hepatitis C as the cause of chronic non-A, non-B hepatitis: high sensitivity of simultaneous measurement of core and non-structural antibodies. J Gastroenterol Hepatol. 1992; 7(5):459-62. DOI: 10.1111/j.1440-1746.1992.tb01020.x. View

Inoue Y, Miyamura T, Unayama T, Takahashi K, Saito I . Maternal transfer of HCV. Nature. 1991; 353(6345):609. DOI: 10.1038/353609a0. View

Everhart J, Di Bisceglie A, Murray L, Alter H, Melpolder J, Kuo G . Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 1990; 112(7):544-5. DOI: 10.7326/0003-4819-112-7-544. View

Manns M, Griffin K, Sullivan K, Johnson E . LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991; 88(4):1370-8. PMC: 295608. DOI: 10.1172/JCI115443. View

Roger S, Crewe E, Cunningham A, Harris D . Hepatitis C virus infection in haemodialysis patients. Aust N Z J Med. 1991; 21(1):22-4. DOI: 10.1111/j.1445-5994.1991.tb02996.x. View

Lin R, Schoeman M, Craig P, Bilous M, Grierson J, McDonald J . Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?. Aust N Z J Med. 1991; 21(3):387-92. DOI: 10.1111/j.1445-5994.1991.tb04715.x. View

10.

Schoeman M, Liddle C, Bilous M, Grierson J, Craig P, Batey R . Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Aust N Z J Med. 1990; 20(1):56-62. DOI: 10.1111/j.1445-5994.1990.tb00372.x. View

11.

Liddle C, Crewe E, Swanson N, Jeffrey G, Cunningham A, REED W . Does hepatitis C virus play a role in "non-viral" chronic liver disease?. Med J Aust. 1990; 153(5):265-71. DOI: 10.5694/j.1326-5377.1990.tb136898.x. View

12.

Fairley C, Leslie D, Nicholson S, Gust I . Epidemiology and hepatitis C virus in Victoria. Med J Aust. 1990; 153(5):271-3. DOI: 10.5694/j.1326-5377.1990.tb136899.x. View

13.

Bell J, Batey R, Farrell G, Crewe E, Cunningham A, Byth K . Hepatitis C virus in intravenous drug users. Med J Aust. 1990; 153(5):274-6. DOI: 10.5694/j.1326-5377.1990.tb136900.x. View

14.

Cossart Y, Kirsch S, Ismay S . Post-transfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet. 1982; 1(8265):208-13. DOI: 10.1016/s0140-6736(82)90770-x. View